Change Country
Welcome to Denmark
Please read the important information below before continuing to our website

By clicking on your client type to enter the website, you are confirming that you have read and understood the important information that is contained below, and you accept the terms of the Privacy and Cookies policy.


The UCITS ETFs listed on this website are funds under both Amundi ETF and Lyxor ETF denomination.

This website is published by Lyxor International Asset Management (LIAM), a French asset management company approved by the AMF (17 place de la Bourse 75082 Paris Cedex 02) under the UCITS (2009/65/EC) and AIFM (2011/31/EU) directives.

The website is hosted by on Microsoft Azure servers.

This website is subject to French and Danish law.


A professional client is a client that is either a per se professional client or an elective professional client (Note article 4 (1) 12 of Mifid )

Marketing Restrictions and Implications


Lyxor UCITS compliant Exchange Traded Funds (Lyxor UCITS ETFs) referred to on this website are open ended mutual investment funds (i) established under the French law and approved by the Autorité des Marchés Financiers (the French Financial Markets Authority), or (ii) established under the Luxembourg law and approved by the Commission de Surveillance du Secteur Financier (the Luxembourg Financial Supervisory Committee). Most of the protections provided by the Danish regulatory system generally and for funds authorised in Denmark do not apply to these exchange traded funds (ETFs).


This website is exclusively intended for persons who are not "US persons", as such term is defined in Regulation S or the US Securities Act 1933, as amended, and who are not physically present in the US. This website does not constitute an offer or an invitation to purchase any securities in the United States or in any other jurisdiction in which such offer or invitation is not authorised or to any person to whom it is unlawful to make such offer or solicitation. Potential users of this website are requested to inform themselves about and to observe any such restrictions.


Index Replication Process


Lyxor UCITS ETFs follow both physical and synthetic index replication process.


However, most Lyxor UCITS ETFs follow synthetic replication process. This consists of entering into a derivative transaction (a ‘Performance Swap’, as defined below) with a counterparty that provides complete and effective exposure to its benchmark index. Lyxor has adopted this methodology in order to minimise tracking error, optimise transaction costs and reduce operational risks.


A Performance Swap is a contractual agreement which is negotiated over-the-counter (OTC) between two parties: the Lyxor UCITS ETF and its counterparty. From a risk perspective, each Performance Swap ranks equally with other senior unsecured obligations of the counterparty, such as common bonds (i.e., same rights to payments). In the Performance Swap, the counterparty of the Lyxor UCITS ETF commits to pay the Lyxor UCITS ETF a variable return based on a pre-determined benchmark index, instead of a fixed stream of income (as in bonds). At the same time, the counterparty will receive from the Lyxor UCITS ETF the performance and any related revenues generated by the basket's assets (excluding the value of the Performance Swap) held by the Lyxor UCITS ETF. Information provided on individual ETFs includes data on the basket relating to the ETF and the percentage value of the basket represented by each asset. The information is relevant to the closing values on the date given. 


Investment Risks


The Lyxor UCITS ETFs described on this website are not suitable for everyone. Investors' capital is at risk. Investors should not deal in this product unless they understand, having obtained independent professional advice where necessary, its nature, terms and conditions, and the extent of their exposure to risk. The value of the product can go down as well as up and can be subject to volatility due to factors such as price changes in the underlying instrument and interest rates. If a fund is quoted in a different currency to the index, currency risks exist.


Prior to any investment in any Lyxor UCITS ETF, you should make your own appraisal of the risks from a financial, legal and tax perspective, without relying exclusively on the information provided by us. We recommend that you consult your own independent professional advisors (including legal, tax, financial or accounting advisors, as appropriate).


Specific Risks


·         Capital at Risk. ETFs are tracking instruments: Their risk profile is similar to a direct investment in the Benchmark Index. Investors’ capital is fully at risk and investors may not get back the amount originally invested. Investments are not covered by the provisions of the Financial Services Compensation Scheme (“FSCS”), or any similar scheme.

·         Counterparty Risk. Investors may be exposed to risks resulting from the use of an OTC Swap with any counterparty. Physical ETFs may have Counterparty Risk resulting from the use of a Securities Lending Programme.

·         Currency Risk. ETFs may be exposed to currency risk if the ETF or Benchmark Index holdings are denominated in a currency different to that of the Benchmark Index they are tracking. This means that exchange rate fluctuations could have a negative or positive effect on returns.

·         Replication Risk. ETFs are designed to replicate the performance of the Benchmark Index. Unexpected events relating to the constituents of the Benchmark Index may impact the Index provider’s ability to calculate the Benchmark Index, which may affect the ETF’s ability to replicate the Benchmark Index efficiently. This may create Tracking Error in the ETF.

·         Underlying Risk. The Benchmark Index of a Lyxor ETF may be complex and volatile. When investing in commodities, the Benchmark Index is calculated with reference to commodity futures contracts which can expose investors to risks related to the cost of carry and transportation. ETFs exposed to Emerging Markets carry a greater risk of potential loss than investment in Developed Markets as they are exposed to a wide range of unpredictable Emerging Market risks.

·         Liquidity Risk. On-exchange liquidity may be limited as a result of a suspension in the underlying market represented by the Benchmark Index tracked by the ETF; a failure in the systems of one of the relevant stock exchanges, Market Maker systems; or an abnormal trading situation or event.


The securities can be neither offered in nor transferred to the United States.




Any statement in relation to tax, where made, is generic and non-exhaustive and is based on our understanding of the laws and practice in force as of the date of this document and is subject to any changes in law and practice and the interpretation and application thereof, which changes could be made with retroactive effect. Any such statement must not be construed as tax advice and must not be relied upon. The tax treatment of investments will, inter alia, depend on an individual’s circumstances. Investors must consult with an appropriate professional tax adviser to ascertain for themselves the taxation consequences of acquiring, holding and/or disposing of any investments mentioned on this website. 

Further information on the risk factors are available in the Risk Warning section of the website.


Any fund prospectus and supplements are available at Information given about the past performance of the funds is no guarantee of future performance. No investment decision should be taken without reading the fund prospectus and any fund supplement of the fund concerned.


Although the content of the website is based upon information that LIAM consider reliable or comes from sources that LIAM consider reliable, LIAM have not verified such information. Lyxor make no representation or warranty as to the accuracy, completeness or adequacy of any information.  Any reproduction, disclosure or dissemination of the materials available on the website is prohibited.



This website uses cookies to make the website work or improve your user experience. Cookies are small text files that are saved on your computer or device, which are used for several purposes such as detecting preferences and improving site navigation. By continuing to use this website you consent for cookies to be used. For more details, including how to amend your preferences, please read our Cookies Policy.

By clicking on your client type to enter the website, you shall be deemed to have represented to us that you are not a U.S. person and that you are not located in the United States of America, its territories and possessions, and any State of the United States of America and that you are authorised to receive the information to and on this website.

August, 2015




We have a new home

Banner Amundi

Read more
09 Apr 2018

Q2 Outlook: Pining for silver linings

The vol strikes back

Equity market volatility made its long-awaited return last quarter. But it’s too soon to say the bubble has burst just yet – in our eyes, the February sell-off was a correction rather than anything more dramatic. The fundamental backdrop remains supportive of stocks – and the “Goldilocks” environment of moderate economic growth and low inflation endures. A number of emerging risks do however mean more bears are on the prowl.

Equities to outperform bonds

What kind of risks are we talking about? First and foremost, central banks are gradually withdrawing their accommodative policies, which will make financial conditions less supportive of risk assets. This is bound to have an effect on their return potential, especially with valuations looking rich.

Other risks include further appreciation of the yen and euro hurting the Japanese and eurozone economies and the re-emergence of protectionism. As it stands, we believe there’s only a 20% chance of a full-blown trade war. That said, we’ve yet to hit peak rhetoric and the key protagonists (Trump and China) still seem intent on taking us to the brink. Global equity markets - Europe in particular - could suffer until they pull back. But pull back they probably will.

If you can see past the clouds, US economic growth still looks firm.  And because this bout of brinkmanship is more negotiating tactic than it is declaration of trade war or a U-turn on globalisation, we still expect equities to outperform bonds in Q2, albeit by a lesser margin than before. 

Break on through...

With the US labour market having become tight, we expect wage inflation to exceed 3% in the coming months. That’s going to feed into higher prices, so we’re overweight US breakevens.

...but beware (some) Treasuries

The exceptional conditions that have artificially suppressed yields since the Global Financial Crisis should continue to fade. Our long-term model suggests ten-year US Treasury yields could rise some way past 3%, so we’re underweight over the long term. Shorter-term however, they retain some of their safe haven appeal should risk aversion spike.  

Neutral, but opportunistic in the US

Although we expect solid top-line earnings growth of around 7% for S&P 500 companies this year, wage growth is likely to dent their profitability and therefore index returns. That means we’re neutral on US equities overall. We’ll bide our time after the recent sell-off – but we will act when the time is right.

For all that, it should still be possible to outperform by taking (and timing) tactical, sectoral and thematic calls. For example, we successfully called growth over value last quarter and believe the story still has room to run. But a note of caution: going short value would mean underweighting banks, which we expect to perform well, so we’re long in banks to offset this

Elsewhere, we still prefer domestically rather than globally oriented stocks, in part because Trump’s trade tantrums could hurt global firms. We’ve closed our overweight in defence stocks as they now appear fully valued, and we’re avoiding consumer discretionary versus staples as the former’s performance has been artificially inflated by just two names: Amazon and Netflix. Amazon, of course, has been firmly in the President’s cross hairs in recent weeks.

Cautious on US high yield

High-yield mutual funds and ETFs have just experienced a record eight consecutive weeks of outflows, although the asset class did weather the spike in volatility in February rather well. But with valuations looking stretched, we’re slightly underweight US high yield.

The jury’s out on Japan

The Japanese economy is doing well, growing more strongly than at any time in the past two decades. And yet while Japanese equities’ fundamentals are supportive both domestically and globally, and they’re trading at a 25% discount to the S&P 500, any rise in the value of the yen would hurt their performance. Taking all this into account, we’re very slightly overweight.

Persevering with eurozone equities

We’re not giving up on eurozone equities just yet. They might be expensive, but they’re still 20% cheaper than US stocks and backed by strong fundamentals. Political risk appears to have eased with Angela Merkel’s return to power in Germany and the relative quiet in Spain. We remain wary of political developments in Italy, but are more constructive on its economic situation. So why have eurozone equities performed so poorly recently? Most likely because of the euro’s rise against the dollar. Since we expect this trend to stall (and perhaps even retreat), we maintain a slight overweight overall. 

Drilling down

Allocating to eurozone small-caps could be a good way of hedging against a single currency surge, while the region’s banks look attractive with the yield curve steepening. We still prefer consumer discretionary to staples, and we also like construction as it should benefit from a pick-up in property prices. At the country level we remain overweight Greek stocks, although we’ve temporarily downgraded French equities from overweight to neutral.

Underweight UK assets

With inflation persistently above the BoE’s long-term target we’re still slightly underweight gilts due to the threat of monetary tightening. Brexit is looming large and the FTSE 100 has underperformed since the start of 2017, so we remain slightly underweight UK equities.

Bullish on emerging equities…

The economic backdrop in most emerging markets is still buoyant, and their central banks are likely to remain accommodative so we’ve moved overweight emerging equities. We see good potential in Taiwan, Malaysia and South Africa, although we’ve moved underweight in India for now.

… but not bonds

We’re not so bullish on bonds from the emerging world. Rising Treasury yields represent a headwind for hard-currency emerging sovereign debt, whose spreads are already tight, so we’re underweight. 

No rich seam for commodities

The drivers of the oil price are numerous and complex, but overall fundamentals have rapidly declined from excellent to average. With the oil price around USD 65 / bbl we’re remaining neutral for now.

Within metals we’re still slightly overweight copper. Its relative valuation seems about fair, but we see medium-term upside due to its role as an inflation hedge. And we’re slightly overweight gold for similar reasons: it’s a good hedge against rising prices and any escalation in trade wars.


Source: All data & opinion Lyxor Cross Asset Research & Equity teams, as at 28 March 2018 unless otherwise stated. Past performance is no guide to future returns.  

Risk Warning


Fund and charge data: Lyxor ETF, correct as at  06 April  2018.

This document is for the exclusive use of investors acting on their own account and categorized either as “Eligible Counterparties” or “Professional Clients” within the meaning of Markets in Financial Instruments Directive 2004/39/EC. These products comply with the UCITS Directive (2009/65/EC). Société Générale and Lyxor International Asset Management (LIAM) recommend that investors read carefully the “investment risks” section of the product’s documentation (prospectus and KIID). The prospectus and KIID are available free of charge on, and upon request to

The products mentioned are the object of market-making contracts, the purpose of which is to ensure the liquidity of the products on the London Stock Exchange, assuming normal market conditions and normally functioning computer systems. Units of a specific UCITS ETF managed by an asset manager and purchased on the secondary market cannot usually be sold directly back to the asset manager itself. Investors must buy and sell units on a secondary market with the assistance of an intermediary (e.g. a stockbroker) and may incur fees for doing so. In addition, investors may pay more than the current net asset value when buying units and may receive less than the current net asset value when selling them. Updated composition of the product’s investment portfolio is available on In addition, the indicative net asset value is published on the Reuters and Bloomberg pages of the product, and might also be mentioned on the websites of the stock exchanges where the product is listed.

Prior to investing in the product, investors should seek independent financial, tax, accounting and legal advice. It is each investor’s responsibility to ascertain that it is authorised to subscribe, or invest into this product. This document is of a commercial nature and not of a regulatory nature. This material is of a commercial nature and not a regulatory nature. This document does not constitute an offer, or an invitation to make an offer, from Société Générale, Lyxor Asset Management (together with its affiliates, Lyxor AM) or any of their respective subsidiaries to purchase or sell the product referred to herein.

Lyxor International Asset Management (LIAM), société par actions simplifiée having its registered office at Tours Société Générale, 17 cours Valmy, 92800 Puteaux (France), 418 862 215 RCS Nanterre, is authorized and regulated by the Autorité des Marchés Financiers (AMF) under the UCITS Directive (2009/65/EU) and the AIFM Directive (2011/31/EU). LIAM is represented in the UK by Lyxor Asset Management UK LLP, which is authorized and regulated by the Financial Conduct Authority in the UK under Registration Number 435658. Société Générale is a French credit institution (bank) authorised by the Autorité de contrôle prudentiel et de résolution (the French Prudential Control Authority).

Research disclaimer

Lyxor International Asset Management (“LIAM”) or its employees may have or maintain business relationships with companies covered in its research reports. As a result, investors should be aware that LIAM and its employees may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision. Please see appendix at the end of this report for the analyst(s) certification(s), important disclosures and disclaimers. Alternatively, visit our global research disclosure website

Conflicts of interest 

This research contains the views, opinions and recommendations of Lyxor International Asset Management (“LIAM”) Cross Asset and ETF research analysts and/or strategists. To the extent that this research contains trade ideas based on macro views of economic market conditions or relative value, it may differ from the fundamental Cross Asset and ETF Research opinions and recommendations contained in Cross Asset and ETF Research sector or company research reports and from the views and opinions of other departments of LIAM and its affiliates. Lyxor Cross Asset and ETF research analysts and/or strategists routinely consult with LIAM sales and portfolio management personnel regarding market information including, but not limited to, pricing, spread levels and trading activity of ETFs tracking equity, fixed income and commodity indices. Trading desks may trade, or have traded, as principal on the basis of the research analyst(s) views and reports. Lyxor has mandatory research policies and procedures that are reasonably designed to (i) ensure that purported facts in research reports are based on reliable information and (ii) to prevent improper selective or tiered dissemination of research reports. In addition, research analysts receive compensation based, in part, on the quality and accuracy of their analysis, client feedback, competitive factors and LIAM’s total revenues including revenues from management fees and investment advisory fees and distribution fees.

Connect with us on linkedin